Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Matterworks
Matterworks

Matterworks

Seed

Matterworks: AI-powered metabolomics for accelerated therapeutic research and development.

HQ
Somerville, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees

Matterworks, founded with the mission to revolutionize metabolomics, leverages AI and analytical chemistry to accelerate therapeutic research, development, and manufacturing. Their core vision is to make biological data more accessible and actionable, thereby enhancing the efficiency of biotechnological advancements. Matterworks offers an AI-enabled platform that deciphers complex biochemical data, providing tools for understanding and predicting biological processes. Their market focus includes pharmaceutical companies, research institutions, and biotech firms seeking to streamline their R&D efforts.

Notable affiliated individuals include experts in AI, biochemistry, and data science, although specific names are not provided. Investors likely include venture capital firms specializing in biotech and AI technologies. Key achievements encompass the successful deployment of their AI platform in various therapeutic research projects, demonstrating significant improvements in data analysis speed and accuracy. Overall, Matterworks has made a substantial impact by enabling more efficient and insightful metabolomics research, thereby accelerating the development of new therapies.

Matterworks - Similar Companies

Manifold Bio logo

Manifold Bio

manifold.bio

Metaphore Biotechnologies logo

Metaphore Biotechnologies

metaphorebio.com

Metanovas Biotech logo

Metanovas Biotech

metanovas.com

Trace Matters logo

Trace Matters

tracematters.com

OmicsCraft logo

OmicsCraft

omicscraft.com

Metabolon logo

Metabolon

metabolon.com

Vibe Bio logo

Vibe Bio

vibebio.com

Manifold logo

Manifold

manifold.ai

Panome Bio logo

Panome Bio

panomebio.com

BioAI Health logo

BioAI Health

bioaihealth.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Tag.bio logo

Tag.bio

tag.bio

Omix.ai logo

Omix.ai

Phenomix Sciences logo

Phenomix Sciences

MolecularCloud logo

MolecularCloud

molecularcloud.org

Matterworks - Quick Facts

Who are Matterworks' competitors?

Companies similar to Matterworks include Manifold Bio, Metaphore Biotechnologies, Metanovas Biotech and Trace Matters.

When was Matterworks founded?

Matterworks was founded in 2019.

Where is Matterworks' headquarters located?

Matterworks' headquarters is located in Somerville, MA, US.

When was Matterworks' last funding round?

Matterworks' most recent funding round was for $7.5M (USD) in August 2023.

How much has Matterworks raised to-date?

As of Aug 14, 2023, Matterworks has raised a total of $13.8M (USD).

How many employees does Matterworks have?

Matterworks has 24 employees as of Feb 4, 2024.

Matterworks - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Metabolomics Platform
Tags
  • Biotech
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software